Strategy

SV Health Investors is a specialist healthcare fund manager, investing across multiple stages and sectors.

SV’s strategy for selecting healthcare investments and adding value is proven and agile. We invest across stages, geographic regions, and sectors, with expertise spanning biotechnology, dementia, healthcare growth, medical technology and public equities.

This has produced consistently strong performance for decades and enabled us to meet the demands of a dynamic industry.

Strategies

Our Current Funds

Historically, SV has managed diversified, multi-sector and multi-strategy healthcare private equity and venture capital funds. As a response to increasingly specialized needs of Limited Partners and entrepreneurs, SV’s seventh vintage of core private funds are split into three distinct vehicles:

  • Impact Medicine Fund, which forms and funds early-stage biotechnology companies developing precision medicines;
  • Growth Fund, which accelerates growth-stage healthcare services, medical products and digital health companies;
  • Medtech Convergence Fund, which specializes in novel medical device and remote-monitoring technologies.

Alongside our core funds, SV manages the Dementia Discovery Fund, focused on discovering and developing novel therapeutics for dementia, and the International Biotechnology Trust plc, a publicly-traded investment trust.